News + Filings Transactions
|
Mattessich Antony C.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/07/2023 | Aura Biosciences, Inc. | AURA | Grant | Stock Option (Right to Buy) | 16k | $12.83 | $205.3k | | 06/07/2023 |
02/06/2023 | OCULAR THERAPEUTIX, INC | OCUL | Sale | Common Stock | 19.7k | $4.24 | $83.4k | | 02/06/2023 |
01/30/2023 | OCULAR THERAPEUTIX, INC | OCUL | Grant | Stock Option (Right to Buy) | 536.9k | $3.88 | $2.1M | | 01/30/2023 |
01/30/2023 | OCULAR THERAPEUTIX, INC | OCUL | Grant | Common Stock | 176.3k | $0.00 | $0 | | 01/30/2023 |
06/15/2022 | Aura Biosciences, Inc. | AURA | Grant | Stock Option (Right to Buy) | 16k | $13.72 | $219.5k | | 06/15/2022 |
02/03/2022 | OCULAR THERAPEUTIX, INC | OCUL | Grant | Stock Option (Right to Buy) | 560.2k | $5.27 | $3M | | 02/03/2022 |
02/03/2022 | OCULAR THERAPEUTIX, INC | OCUL | Grant | Common Stock | 186.8k | $0.00 | $0 | | 02/03/2022 |
10/28/2021 | Aura Biosciences, Inc. | AURA | Grant | Stock Option (Right to Buy) | 16k | $14.00 | $224k | | 10/28/2021 |
08/20/2021 | OCULAR THERAPEUTIX, INC | OCUL | Purchase | Common Stock | 5k | $9.89 | $49.4k | | 08/20/2021 |
02/17/2021 | OCULAR THERAPEUTIX, INC | OCUL | Grant | Stock Option (Right to Buy) | 455k | $18.31 | $8.3M | | 02/17/2021 |
01/30/2020 | OCULAR THERAPEUTIX, INC | OCUL | Grant | Stock Option (Right to Buy) | 360k | $4.39 | $1.6M | | 01/30/2020 |
06/06/2019 | OCULAR THERAPEUTIX, INC | OCUL | Purchase | Common Stock | 40k | $2.81 | $112.4k | | 06/06/2019 |
01/02/2019 | OCULAR THERAPEUTIX, INC | OCUL | Grant | Stock Option (Right to Buy) | 400k | $4.10 | $1.6M | | 01/02/2019 |
08/20/2018 | OCULAR THERAPEUTIX, INC | OCUL | Purchase | Common Stock | 20k | $5.95 | $119k | | 08/20/2018 |
08/10/2018 | OCULAR THERAPEUTIX, INC | OCUL | Purchase | Common Stock | 16.9k | $6.23 | $105.3k | | 08/10/2018 |
01/31/2018 | OCULAR THERAPEUTIX, INC | OCUL | Grant | Stock Option (Right to Buy) | 360k | $5.47 | $2M | | 01/31/2018 |
12/12/2017 | OCULAR THERAPEUTIX, INC | OCUL | Purchase | Common Stock | 21k | $4.29 | $90.1k | | 12/12/2017 |
|